Regulatory Updates: Page 28

Head/neck cancer treatment gets FDA approval
By DrBicuspid.com staff writers
Bristol-Myers Squibb announced that the U.S. Food and Drug Administration (FDA) has approved its Opdivo intravenous injection for patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
November 10, 2016
CMS delays Medicare enrollment rule to 2019
By Theresa Pablos
Dentists may get a temporary reprieve from a U.S. government program designed to get a handle on the country's opiate crisis. The U.S. Centers for Medicare and Medicaid Services (CMS) said it has delayed by two years the date by which dentists must be enrolled with the government to be able to prescribe powerful Part D drugs such as opiates.
November 8, 2016
2016 11 08 17 16 22 259 Denied 400
ADA vote allows specialists to practice outside specialty
By Donna Domino
Specialists will be able to practice outside their announced specialty, according to a resolution approved by the ADA House of Delegates during the 2016 annual meeting. The change was expected after a U.S. judge ruled earlier in 2016 that a Texas regulation barring dentists from advertising themselves as "specialists" was unconstitutional.
October 31, 2016
2016 10 31 16 18 11 359 Ada Logo 400
Calif. passes bill to track preventive dental services
By DrBicuspid.com staff writers
California Gov. Jerry Brown signed a bill on September 25 that expands the state's required monitoring of preventive dental services.
September 27, 2016
Court: Ohio dentist's advertising lawsuit can proceed
By Donna Domino
An appellate court has ruled that a lawsuit filed by an Ohio dentist regarding advertising as a specialist can proceed. The suit focuses on an Ohio law that forbids dentists from advertising as specialists when they also perform general dentistry.
September 1, 2016
2016 09 01 13 52 16 412 Gavel 400
FDA requires boxed warnings on opioids, benzodiazepine
By DrBicuspid.com staff writers
The U.S. Food and Drug Administration (FDA) announced that it will require boxed warnings for prescription opioid analgesics, opioid-containing cough products, and benzodiazepines.
August 31, 2016
Snuggie maker to drop claims for interdental cleaner
By DrBicuspid.com staff writers
Consumer brand developer and marketer Allstar Products Group, maker of the Snuggie and other products, will voluntarily remove some claims in its television commercial for Dr. Hart's Power Floss after an inquiry by the Better Business Bureau.
August 28, 2016
JAMA editorial: San Francisco sugary drink decision a victory
By Donna Domino
San Francisco is the first U.S. city to require health warnings on ads for sodas and sugary drinks. The pioneering law is a victory over the beverage industry's efforts to manipulate science, according to the authors of an editorial in the Journal of the American Medical Association (JAMA).
August 8, 2016
2016 08 08 15 57 05 753 Soda 400
DentaQuest to purchase stake in Ore. dental plan
By DrBicuspid.com staff writers
DentaQuest has received regulatory approval to purchase 80% of a company that operates more than 40 dental clinics in Oregon.
August 7, 2016
U.S. bill to fight opioid epidemic becomes law
By DrBicuspid.com staff writers
A U.S. bill that provides resources to battle the ongoing opioid epidemic was signed into law by President Barack Obama on July 22.
July 27, 2016
Advertising body backs Oral-B toothbrush claims
By DrBicuspid.com staff writers
The National Advertising Division of the Council of Better Business Bureaus has determined that Procter & Gamble's advertising claims about the superior clean of its Oral-B Pro 5000 and 70000 electric toothbrushes are supported by scientific evidence.
July 26, 2016
FDA approves St. Renatus' nasal spray anesthetic
By DrBicuspid.com staff writers
The U.S. Food and Drug Administration (FDA) has approved St. Renatus' nasal anesthetic, Kovanaze, for dentistry.
July 11, 2016
Previous Page
Page 28 of 73
Next Page